Emerald Investment Advisers »

Vertex Pharmaceuticals Incorporated shares owned by Emerald Investment Advisers

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Emerald Investment Advisers from 13F filings

Historical chart of Emerald Investment Advisers investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Emerald Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Emerald Investment Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.6M 8.0k 446.54

More positions owned by Emerald Investment Advisers

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Ishares Tr Msci Eafe Etf (EFA)
Cisco Systems (CSCO)
Eli Lilly & Co. (LLY)
Lam Research Corp Com New (LRCX)
Raytheon Technologies Corp (RTX)
Wintrust Financial Corporation (WTFC)
Morgan Stanley Com New (MS)

View all positions for Emerald Investment Advisers

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Alliancebernstein
Wellington Management Company
Victory Capital Management
Morgan Stanley
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated